Asthma is a heterogeneous inflammatory disease of the airways that causes breathing
difficulties, episodes of cough and wheezing, and in more severe cases can greatly diminish …

Asthma is a disease with high incidence and prevalence, and its severe form accounts for
approximately 10% of asthmatics. Over the last decade, the increasing knowledge of the …

Background Type 2 inflammation is common in children with asthma. Dupilumab, a human
antibody, blocks the signaling of interleukin-4 and-13, key and central drivers of type 2 …

Although airway remodeling in severe and/or fatal asthma is stil considered irreversible, its
individual components as a cause of clinical symptoms and/or lung function changes remain …

Pulmonary arterial hypertension (PAH) is a rare, complex, and deadly cardiopulmonary
disease. It is characterized by changes in endothelial cell function and smooth muscle cell …

This systematic review evaluates the effectiveness of the Kansas City Cardiomyopathy
Questionnaire (KCCQ) in assessing quality of life improvements among patients with heart …

Asthma is a chronic respiratory disease that poses significant individual, social, financial and
healthcare burdens. Physicians and researchers have recommended 25-hydroxy vitamin D …

As the global population ages, pulmonary diseases among older people have emerged as a
significant and growing public health concern. The increasing incidence of these conditions …

Background and Objectives While achieving complete radiological improvement in patients
with nasal polyps is often observed following surgical resection, the impact of biologic …

Dupilumab inhibiting the signaling of interleukin (IL)-4 and IL-13 was recommended for the
treatment of severe asthma in children≥ 6 years old according to the Global Initiative for …